More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary HempMeds® Brazil Announces Prominent Coverage in Brazilian Newspapers After Legal Victory

Medical Marijuana, Inc. Subsidiary HempMeds® Brazil Announces Prominent Coverage in Brazilian Newspapers After Legal Victory

by adminTorusBrand | Oct 25, 2017 | HempMeds Brasil, Press Releases

Federal Judge in Brazil Orders the Government to Subsidize Payments for Real Scientific Hemp Oil™ (RSHO™) for Brazilian Citizen SAN DIEGO, Oct. 24, 2017 — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States,...
HempMeds® Brasil Featured in Coverage on the Use of CBD Oil in Brazil

HempMeds® Brasil Featured in Coverage on the Use of CBD Oil in Brazil

by adminTorusBrand | Oct 2, 2017 | HempMeds Brasil, Media Coverage

Portalodia article reports one family’s experience using RSHO™ CBD oil products in Brazil. Medical Marijuana, Inc. subsidiary HempMeds® Brasil was mentioned this week in an online article on portalodia.com detailing the use of CBD oil by a young girl in Brazil. After...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds Establishment of Patient Association in Brazil to Provide Cannabis Patients Greater Access

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds Establishment of Patient Association in Brazil to Provide Cannabis Patients Greater Access

by adminTorusBrand | Oct 2, 2017 | HempMeds Brasil, Press Releases

New Patient Association Focuses on Connecting Patients with Cannabis-Friendly Doctors, Educating Brazilian Medical Community and Citizens on Therapeutic Uses of Cannabis SAN DIEGO, Oct. 2, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds Establishment of Patient Association in Brazil to Provide Cannabis Patients Greater Access

Article in Valor Features HempMeds® Brasil and the Growing Cannabis Market

by adminTorusBrand | Aug 31, 2017 | HempMeds Brasil, Media Coverage

Medical Marijuana, Inc. and its subsidiary HempMeds® Brasil were the focus of a recent article in Brazilian economic news source Valor. Meaning value in English, Valor is Brazil’s largest financial publication. The daily weekday newspaper sells nearly 60,000...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil’s Sold-Out Doctor Symposium on Medical Cannabis Garners Vast Media Coverage Across Brazil

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil’s Sold-Out Doctor Symposium on Medical Cannabis Garners Vast Media Coverage Across Brazil

by adminTorusBrand | Aug 23, 2017 | HempMeds Brasil, Press Releases

SAN DIEGO, Aug. 23, 2017  — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil held a successful, sold-out Doctor Symposium in Sao Paulo, Brazil on August 15, with...
« Older Entries

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Subscribe for Company Updates

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.